ArriVent BioPharma, Inc.
(NASDAQ: AVBP)
Arrivent Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in identifying, licensing, and globalizing biopharma innovations from around the world to deliver important medicines to patients. The company was founded Zheng Bin Yao and Stuart Lutzker on April 14, 2021 and is headquartered in Newtown Square, PA.
24.350
+1.470
(+6.42%)
Range
22.890 - 24.508
(7.07%)
Open
22.890
Previous Close
22.880
Bid Price
-
Bid Volume
-
Ask Price
-
Ask Volume
-
Volume
926,456
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
